Search Prime Grants

W81XWH2110565

Project Grant

Overview

Grant Description
Advancement of CRISPR-based Adipose Tissue Therapies for Type 2 Diabetes to Nonhuman Primates
Awardee
University Of Massachusetts Medical School
Funding Goals
PEER REVIEWED MEDICAL RESEARCH PROGRAM AWARD MECHANISM: FOCUSED PROGRAM AWARD
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Worcester, Massachusetts 016550001 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH20PRMRPFPA
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/14/25 to 08/14/26.
University Of Massachusetts Medical School was awarded CRISPR-Based Adipose Therapies for Type 2 Diabetes in Primates Project Grant W81XWH2110565 worth $9,706,177 from Defense Health Agency in August 2021 with work to be completed primarily in Worcester Massachusetts United States. The grant has a duration of 5 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 7/18/25

Period of Performance
8/15/21
Start Date
8/14/26
End Date
80.0% Complete

Funding Split
$9.7M
Federal Obligation
$0.0
Non-Federal Obligation
$9.7M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2110565

Subgrant Awards

Disclosed subgrants for W81XWH2110565

Transaction History

Modifications to W81XWH2110565

Additional Detail

Award ID FAIN
W81XWH2110565
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
State Government
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
MQE2JHHJW9Q8
Awardee CAGE
6R004
Performance District
MA-02
Senators
Edward Markey
Elizabeth Warren
Modified: 7/18/25